会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 29. 发明专利
    • Bispecific EGFR/c-Met antibodies
    • AU2021202394A1
    • 2021-05-20
    • AU2021202394
    • 2021-04-20
    • JANSSEN BIOTECH INC
    • CHIU MARKMOORES SHERINEIJSSEN JOOSTSCHUURMAN JANINEPARREN PAUL
    • C07K16/00
    • Figure IA. NO: 18 LPAPKNLVVSEVTEDSLRLSWNDP-HGFYDSFLIQYQESEKVGEAINLTVPGSERSYDLTG (60) 19 LPAPKNLVVSEVTEDSLRLSWrYD-RDGY SFLIQYQESEKVGEAINLTVPGSERSYDLTG 20 LPAPKNLVVSEVTEDSLRLSW3YN-GDHE SFLIQYQESEKVGEAINLTVPGSERSYDLTG 21 LPAPKNLVVSEVTEDSLRLSW DP-RGFY GSFLIQYQESEKVGFAINLTVPGSERSYDLTG 22 LPAPKNLVVSEVTEDSLRLSWrWP-YADL'SFLIQYQESEKVGRAINLTVPGSERSYDLTG 23 LPAPKNLVVSEVTEDSLRLSW YN-GDHF2SFLIQYQESEKVGEAINLTVPGSERSYDLTG 24 LPAPKNLVVSEVTEDSLRLSW YDLGDHF SFLIQYQESEKVGEAINLTVPGSERSYDLTG 25 LPAPKNLVVSEVTEDSLRLSW DP-WAFY CSFLIQYQESEKVGEAINLTVPGSERSYDLTG 27 LPAPKNLVVSEVTEDSARLSW DP-WAFY SFLIQYQESEKVGEAIVLTVPGSERSYDLTG 29 LPAPKNLVVSEVTEDSLRLSW WP-YADL SFLIQYQESEKVGEAINLTVPGSERSYDLTG 107 LPAPKNLVVSEVTEDSARLSW DP-HGFY SFLIQYQESEKVGEAIVLTVPGSERSYDLTG 108 LPAPKNLVVSEVTEDSARLSW DP-WAFY SFLIQYQESEKVGEAIVLTVPGSERSYDLTG 109 LPAPKNLVVSEVTEDSARLSW DP-HAF SFLIQYQESEKVGEAIVLTVPGSERSYDLTG 110 LPAPKNLVVSEVTEDSARLSWEDP-HGFY SFLIQYQESEKVGEAIVLTVPGSERSYDLTG 18 LKPGTEYTVSIYGV INVYKDTNMRGI PLSAEFTT (94) 19 LKPGTEYTVSIYGV INVYKDTNMRG PLSAEFTT 20 LKPGTEYTVSIYGVINVYKDTNMRGIPLSAEFTT 21 LKPGTEYTVSIYGViNVYKDTNMRGIPLSAEFTT 22 LKPGTEYTVSIYGViNVYKDTNMRGIPLSAEFTT 23 LKPGTEYTVSIYGV NVYKDTNMRGI PLSAEFTT 24 LKPGTEYTVSIYGV NVYKDTNMRGI PLSAEFTT 25 LKPGTEYTVSIYGV JNVYKDTNMRGI PLSAEFTT 27 LKPGTEYTVSIYGV NVYKDTNMRGI PLSAIFTT 29 LKPGTEYTVSIYGV INVYKDTNMRGI PLSAEFTT 107 LKPGTEYTVSIYGV INVYKDTNMRGI PLSAIFTT 108 LKPGTEYTVSIYGV INVYKDTNIRGI PLSAIFTT 109 LKPGTEYTVSIYGV INVYKDTNIRGI PLSAIFTT 110 LKPGTEYTVSIYGV NVYKDTIRGI PLSAIFTT Bispecific EGFR/c-Met antibodies and methods making and using the molecules. Epidermal growth factor receptor (EGFR, ErbBI or HERI) is a Type I transmembmne glycoprotein of 170 kDa thai is encoded by the c-erbBI proto-oncogene. EGFR is a member of the human epidermal growth factor receptor (HER) family of receptor tyrosine kinases (RTK) which includes HER2 (ErbB2), HER3 (ErbB3) and HER4 (ErbB4). EGFR signaling is initiated by ligand binding followed by induction of conformational change, homodimerizalion or heteromdimerization of the receptor with other ErbB family members.